ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OSLO OncoSil Medical Ltd

0.001
0.00 (0.00%)
23 Dec 2024 - Closed
Delayed by 20 minutes
Share Name Share Symbol Market Type
OncoSil Medical Ltd ASX:OSLO Australian Stock Exchange Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.001 0.001 0.002 0.00 00:00:00

DNO International:3rd Party Arbitration Not Part Of Kurdish Suspension

01/10/2009 8:18am

Dow Jones News


OncoSil Medical (ASX:OSLO)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more OncoSil Medical Charts.

DNO International ASA (DNO.OS) Thursday said an ongoing arbitration process between it and an unnamed third party about certain Kurdish oil assets are not a part of the suspension period in Kurdistan.

"There has been no formal statement of claim specifying the damages requested in the arbitration to date. During our ongoing discussions with the Kurdish Regional Government, we have understood that the arbitration is not part of the present suspension period in Kurdistan, which DNO is working to resolve as soon as possible," the company said in a statement.

DNO said the proceedings are confidential and will not divulge the identity of the third party whose claims to Kurdish interests it has rejected.

Earlier this month, KRG suspended DNO's oil operations and exports in Kurdistan on the basis that misleading and incomplete publications by the Oslo Stock Exchange relating to a DNO share sale caused unjustifiable and incalculable harm to the KRG. It said at the time that DNO had six weeks to remedy damage done to the KRG's reputation, sort out its internal issues with the stock exchange and "any other disputes that they may have with any other third parties with respect to any claims related to the production-sharing contracts." Market watchers understood that to mean DNO might have to resolve its ongoing arbitration proceedings more quickly.

Web site: www.dno.no

-By Elizabeth Adams, Dow Jones Newswires; +44 (0) 20 7842 9386; elizabeth.adams@dowjones.com

 
 

1 Year OncoSil Medical Chart

1 Year OncoSil Medical Chart

1 Month OncoSil Medical Chart

1 Month OncoSil Medical Chart

Your Recent History

Delayed Upgrade Clock